Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
14,468 total articles
Expro (XPRO) is a niche oilfield-services play benefiting from rising well complexity and a $2.3B contract backlog. With recent beat in Q2 2025 revenue ($422.7M) and a market cap near $1.97B, the risk/reward favors a tactical long over the next 45 trading days as contracts roll into revenue and margin mix improves. Entry at $17.58, target $20.00, s…
The Bancorp (TBBK) is trading near its 52-week low despite improving fintech fee growth, expanding deposits, and healthy profitability metrics. With a trailing P/E near 9x, a $2.06B market cap, and clear cost-containment efforts, the risk-reward favors a tactical long over the next 45 trading days if management continues execution. This trade idea …
Chevron is trading near multi-month highs with a 3.3%+ yield, robust free cash flow, low net leverage and material upside if $100 oil persists. I lay out a concrete long trade: entry $214.04, stop $197.00, target $255.00 (180 trading days) plus shorter horizon guidance. The set-up balances cyclical oil exposure with solid downstream cash generation…
Advanced Micro Devices remains a leading beneficiary of the AI infrastructure cycle with high-margin products, improving profitability, and healthy free cash flow. However, AMD now trades at a premium - with a market cap near $845B and a P/E north of 120x - leaving less margin for execution risk. I downgrade from Buy to Neutral and recommend an opp…
Meta's headline losses from Reality Labs and short-term ad noise have created a dislocation. With strong cash generation, tightening cost discipline, and clear revenue optionality from AI and long-form video, the risk-reward favors a disciplined long. This trade plan lays out an entry at $550, a stop at $480 and a $700 target with catalysts and ris…
Talen Energy's recent asset deal, debt repricing and visible free cash flow create a measured long trade for investors looking to play infrastructure that benefits from rising AI/data-center power demand. Valuation still looks stretched on leverage metrics, but the company now sits on roughly $444M of free cash flow against a $15.0B market cap and …
Precision Drilling (PDS) is a levered play on U.S. onshore margin recovery. The shares trade at a modest $1.14B market cap with P/B ~1.02 and a negative P/E, leaving room for a rerating if U.S. pricing and utilization rebound. Technicals are mixed but constructive; short interest has climbed, creating asymmetric upside if fundamentals surprise to t…
Trulieve looks positioned to benefit from easing regulatory pressure and improving operational leverage. This trade idea lays out a long entry with explicit entry, stop and target, catalysts to watch, and risks that could invalidate the thesis.
Micron sits at the intersection of surging AI infrastructure demand and scarce premium memory supply. The company's record revenue and profits, exceptional returns on capital, and a fortress-like balance sheet justify a long exposure. This trade idea outlines an actionable entry, stop, and target with a 180-trading-day horizon and balanced risks.
On Holding (ONON) has been hit hard by post-earnings skepticism, but the underlying business shows durable DTC growth, expanding gross margins, and accelerating APAC penetration. We present a tactical long with a clear entry, stop and target on a 45-trading-day horizon that balances upside from a recovery in sentiment and fundamentals against near-…
Western Digital has been punished hard from its 52-week peak, but the underlying compounding demand from AI and cloud data centers remains intact. The company reported 36% fiscal 2026 revenue growth, $3.51B in free cash flow and a net cash position, yet the stock sits far below its highs. This trade idea lays out an actionable long with entry, stop…
At roughly $5.40 per share and a $20.4B market cap, Stellantis looks priced for disappointment. That pessimism is overdone in my view. Low book multiple, heavy short interest, and stabilizing technicals set up a mid-term (45 trading days) tactical long to $8.00 with a tight stop below the 52-week low. This is a trade, not a full conviction buy.
Microsoft remains the safest scaled play on AI infrastructure and enterprise software. At $495, the stock offers a reasonable risk-reward: durable free cash flow, a healthy balance sheet and secular exposure to AI and cloud adoption. Technicals show near-term consolidation; we prefer a limit entry near $492.44, a $470 stop and a $540 target over th…
Alkermes trades like a commercial-stage CNS company with a sizable market cap ($7.7B), steady free cash flow (~$222M last reported) and an active pipeline. The stock sits below its 52-week high ($55.67) after a year of M&A and pipeline repositioning. I view ALKS as a long with a 180-trading-day horizon: the base business finances optionality, while…
Intuitive Machines finished Q2 with a record $1.8 billion backlog and $920 million in awards, setting the revenue runway for 2026 and beyond. Revenue growth is real (Q2 revenues of $206.2M, +310% YoY) and the company expects 25-30% of backlog to convert to 2026 revenue. That makes LUNR a tactical long for patient traders who accept execution risk: …
Ocugen (OCGN) trades near $1 with a market cap around $342M. With 12-month Phase 2 data for its modifier gene therapy program being presented at industry meetings in September, this trade idea targets a mid-term move into and through the data event. The setup leans long into the catalyst while explicitly hedging around heavy short interest, thin te…
Oracle's recent drop is driven by angst over $55.7B in FY2026 capex, a projected $70B in FY2027, and a planned $40B financing package. Those are big numbers, but they sit against a gargantuan $638B remaining performance obligation and accelerating cloud revenue. We view the selloff as an overreaction. Enter at $151.24 with a $225 target over a 180 …
Verizon (VZ) combines a 5.6% yield, healthy free cash flow and improving service convergence (wireless + fixed + edge + enterprise) at a reasonable valuation. We present a mid-term trade idea that leans into catalyst-driven re-rating while protecting capital with a tight stop.
Southern Company (SO) trades near $88 with a $101B market cap, 12.8x EV/EBITDA and an 11% ROE. Negative free cash flow and high leverage are real issues, but rate-base growth, data-center load wins and a supportive regulatory backdrop make the stock a buy for a 180-trading-day horizon with defined entry, stop and target.
Taysha (TSHA) is a clinical-stage AAV gene therapy company whose lead program, TSHA-102 for Rett syndrome, has advanced through pivotal dosing and gained regulatory alignment on manufacturing and BLA strategy. With roughly $320M in cash, a completed $200M offering in June, and a market cap near $1.6B, TSHA offers asymmetric upside if clinical reado…
BSX has collapsed from a $105 52-week high to $43 and is trading at valuation levels that reflect a tough 2026. The company still generates strong free cash flow, has manageable leverage, and a product pipeline exposed to growing adjacencies (IVL, renal denervation, AF devices). This trade idea outlines a mid-term long with explicit entry, stop, an…
Apple’s first mainstream foldable, the iPhone Duo (branded iPhone Ultra in some reports), paired with broad carrier distribution and Apple's services moat, gives the company a clear path to dominate premium foldables. The stock trades on a premium multiple but is backed by $136.7B in free cash flow and a $4.89T market cap. I recommend a long trade …
Sandisk's NAND-focused franchise sits squarely in the path of accelerating AI storage demand. Strong margins, $11.5B in free cash flow and favorable technical momentum support a long trade targeting a >2x outcome to 2030, paired with a measured stop to control downside.
Western Digital has moved from cyclical volatility to contract-backed growth. With fiscal 2026 revenue up ~36% and $3.51B in free cash flow, the company is funding buybacks and dividends while ramping higher-capacity drives for AI-driven data centers. This trade targets a mid-term snapback to the $500+ area on continued contract fulfillment and mar…
BioCryst (BCRX) pulled back into the low-$8s after an extended run. Fundamentals now show durable ORLADEYO revenue, a strong free cash flow print and a near-term catalyst calendar (data presentations, ongoing navenibart pivotal enrollment) that could re-rate the stock. This trade idea lays out a mid-term long with clear entry, stop and target and e…
